East Amherst, NY, United States of America

David G Hangauer

This inventor holds 23 USPTO granted patents, plus 6 CIPO patents and 5 EPO patents, primarily in CNS Drug Development. Top assignees: Hypnion, Inc., Merck + Co., Inc., The State University of New York. Active years: 1993-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David G Hangauer. Retrieved from https://idiyas.com/inventor/david-g-hangauer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23

% Patents Active = 34.8

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 5

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 151(Granted Patents)

Location History:

East Amherst, NY (US) (1993 - 2012)
Est Amherst, NY (US) (2012)
East Amberst, NY (US) (2012)

Company Filing History:

The State University of New York

patents

4. 1 out of 313

Health Research, Inc.

patents

5. 1 out of 2

Roswell Park Cancer Institute

patents

where one patent can have more than one assignee

Years Active: 1993-2012

Loading Chart...

Areas of Expertise:

CNS Disorders

Kinase Inhibitors

Angiotensin II Antagonists

Benzisoxazole Compounds

Sleep Disorders

Protein-Protein Interactions

Quetiapine Analogs

Doxepin Analogs

High Throughput Assays

Naphthalene Scaffolds

Loxapine Analogs

Piperidine Compounds

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8129410 - Benzisoxazole piperidine compounds and methods of use thereof (2012-03-06),

2. 8101596 - Loxapine analogs and methods of use thereof (2012-01-24),

3. 8088778 - Benzisoxazole piperazine compounds and methods of use thereof (2012-01-03),

4. 7968708 - Azepans and methods for making and using same (2011-06-28),

5. 7901894 - Kinase inhibitors (2011-03-08),

6. 7807828 - Olanzapine analogs and methods of use thereof (2010-10-05),

7. 7662750 - Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds (2010-02-16),

8. 7592333 - Loxapine analogs and methods of use thereof (2009-09-22),

9. 7563785 - Quetiapine analogs and methods of use thereof (2009-07-21),

10. 7524864 - Methods of treating sleep disorders (2009-04-28),

11. 7494998 - Benzisoxazole piperazine compounds and methods of use thereof (2009-02-24),

12. 7482460 - Doxepin analogs and methods of use thereof (2009-01-27),

13. 7411069 - Doxepin analogs and methods of use thereof (2008-08-12),

14. 7355042 - Treatment of CNS disorders using CNS target modulators (2008-04-08),

15. 7326721 - Doxepin analogs and methods of use thereof (2008-02-05),

Title: Celebrating the Innovations of David G Hangauer

Introduction

David G Hangauer, based in East Amherst, NY, is an accomplished inventor with a remarkable portfolio of 23 patents. His groundbreaking work primarily focuses on the development of compounds that modulate sleep, showcasing his commitment to improving health through innovative solutions.

Latest Patents

Among his latest patents is the invention titled "Benzisoxazole piperidine compounds and methods of use thereof." This invention details benzisoxazole piperidine compositions that are utilized for modulating sleep. Another notable patent is for "Loxapine analogs and methods of use thereof," which introduces novel compounds and methods aimed at enhancing sleep modulation.

Career Highlights

Throughout his career, David has contributed significantly to the field of pharmaceutical research. He has held positions at esteemed companies such as Hypnion, Inc. and Merck & Company, Inc., where he applied his expertise to advance therapeutic solutions.

Collaborations

David's innovative journey has been enriched by collaboration with other talented professionals, including Dale M Edgar and James F White. Their collective efforts have fostered an environment of creativity and progress in the research and development of sleep-related compounds.

Conclusion

David G Hangauer exemplifies the spirit of innovation through his impactful patents and dedication to improving sleep health. His contributions not only highlight the importance of collaboration in research but also demonstrate the potential of inventive solutions in enhancing quality of life.

Profile summary based on public USPTO records.